Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

83 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Does medicalization of life imperil health? Expanding indications for diagnosis and treatment of chronic "disease".
Fairman KA, Curtiss FR. Fairman KA, et al. J Manag Care Pharm. 2011 Jul-Aug;17(6):469-80. doi: 10.18553/jmcp.2011.17.6.469. J Manag Care Pharm. 2011. PMID: 21787033 No abstract available.
How do seniors respond to 100% cost-sharing for prescription drugs? Quality of the evidence underlying opinions about the Medicare Part D coverage gap.
Fairman KA, Curtiss FR. Fairman KA, et al. J Manag Care Pharm. 2011 Jun;17(5):382-92. doi: 10.18553/jmcp.2011.17.5.382. J Manag Care Pharm. 2011. PMID: 21657807
Protecting patients from adverse drug events: propoxyphene, PIMs, and drugs to avoid in older adults.
Curtiss FR, Fairman KA. Curtiss FR, et al. Among authors: fairman ka. J Manag Care Pharm. 2011 Jan-Feb;17(1):60-9. doi: 10.18553/jmcp.2011.17.1.60. J Manag Care Pharm. 2011. PMID: 21204591 No abstract available.
No TREATment with darbepoetin dosed to hemoglobin 13 grams per deciliter in type 2 diabetes with pre-dialysis chronic kidney disease--safety warnings for erythropoiesis-stimulating agents.
Curtiss FR, Fairman KA. Curtiss FR, et al. Among authors: fairman ka. J Manag Care Pharm. 2009 Nov-Dec;15(9):759-65. doi: 10.18553/jmcp.2009.15.9.759. J Manag Care Pharm. 2009. PMID: 19954267 No abstract available.
VBID, the PPACA, and FREEE medications: Did politics trump the evidence about cost sharing?
Fairman KA, Curtiss FR. Fairman KA, et al. J Manag Care Pharm. 2012 Mar;18(2):146-55. doi: 10.18553/jmcp.2012.18.2.146. J Manag Care Pharm. 2012. PMID: 22380473 No abstract available.
Why hypotheses informed by observation are often wrong: results of randomized controlled trials challenge chronic disease management strategies based on epidemiological evidence.
Fairman KA. Fairman KA. J Manag Care Pharm. 2011 Apr;17(3):224-31. doi: 10.18553/jmcp.2011.17.3.224. J Manag Care Pharm. 2011. PMID: 21434699 No abstract available.
Regulatory actions on the off-label use of prescription drugs: ongoing controversy and contradiction in 2009 and 2010.
Fairman KA, Curtiss FR. Fairman KA, et al. J Manag Care Pharm. 2010 Oct;16(8):629-39. doi: 10.18553/jmcp.2010.16.8.629. J Manag Care Pharm. 2010. PMID: 20866167 No abstract available.
Tough questions about the value of statin therapy for primary prevention: did JUPITER miss the moon?
Curtiss FR, Fairman KA. Curtiss FR, et al. Among authors: fairman ka. J Manag Care Pharm. 2010 Jul-Aug;16(6):417-23. doi: 10.18553/jmcp.2010.16.6.417. J Manag Care Pharm. 2010. PMID: 20635832 No abstract available.
Contradictory actions on off-label use of prescription drugs? The FDA and CMS versus the U.S. Justice Department.
Curtiss FR, Fairman KA. Curtiss FR, et al. Among authors: fairman ka. J Manag Care Pharm. 2009 Mar;15(2):161-5. doi: 10.18553/jmcp.2009.15.2.161. J Manag Care Pharm. 2009. PMID: 19236131 No abstract available.
Prior authorization and clopidogrel use--the truth lies in the details.
Jackson MA, Fairman KA, Curtiss FR. Jackson MA, et al. Among authors: fairman ka. J Manag Care Pharm. 2009 Jan-Feb;15(1):71-7. doi: 10.18553/jmcp.2009.15.1.71. J Manag Care Pharm. 2009. PMID: 19125553 No abstract available.
83 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page